Marquet Magda sold AnaptysBio, Inc. ($ANAB) shares on the open market twice in the last year, totaling about $531,000. Her most recent sale occurred on January 15, 2026. These sales rank her 6,308th among 11,678 individual insiders by value sold, below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | S | Common Stock | 9290 | $48.12 | 11,640.0000 | 27,688,470 | 44.39% | 0.03% |
| Jan. 15, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 27,688,470 | 100.00% | 0.04% |
| Jan. 15, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | S | Common Stock | 1710 | $48.85 | 9,930.0000 | 27,688,470 | 14.69% | 0.01% |
| Jan. 15, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Common Stock | 11000 | $26.11 | 20,930.0000 | 27,688,470 | 110.78% | 0.04% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | A | Restricted Stock Unit | 4000 | $0.00 | 4,000.0000 | 27,688,470 | 9999.99% | 0.01% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | A | Stock Option (right to buy) | 5500 | $0.00 | 5,500.0000 | 27,688,470 | 9999.99% | 0.02% |
| June 20, 2025 | Immix Biopharma, Inc. | $IMMX | Marquet Magda | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 27,722,108 | 9999.99% | 0.12% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Restricted Stock Unit | 6030 | $0.00 | 0.0000 | 30,666,781 | 100.00% | 0.02% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Common Stock | 6030 | $0.00 | 9,930.0000 | 30,666,781 | 154.62% | 0.02% |
| June 9, 2025 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Immix Biopharma, Inc. | $IMMX | Marquet Magda | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | M | Common Stock | 3131 | $0.00 | 28,073.0000 | 0 | 12.55% | 0.00% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Transcode Therapeutics, Inc. | $RNAZ | Marquet Magda | Director | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 155,831 | 9999.99% | 44.92% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Common Stock | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Not found | M | Restricted Stock Unit | 3900 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 20, 2024 | Immix Biopharma, Inc. | $IMMX | Marquet Magda | Director | A | Common Stock | 21155 | $0.00 | 66,092.0000 | 0 | 47.08% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Marquet Magda | Director | A | Common Stock | 25002 | $0.00 | 45,002.0000 | 0 | 125.01% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Director | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Director | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | Marquet Magda | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | Transcode Therapeutics, Inc. | $RNAZ | Marquet Magda | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 10, 2023 | Transcode Therapeutics, Inc. | $RNAZ | Marquet Magda | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 18,593 | 9999.99% | 51.09% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Director | A | Stock Option (right to buy) | 10600 | $0.00 | 10,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Marquet Magda | Director | A | Restricted Stock Unit | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |